Logotype for Candel Therapeutics Inc

Candel Therapeutics (CADL) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Candel Therapeutics Inc

Proxy filing summary

29 Apr, 2026

Voting matters and shareholder proposals

  • Election of four Class II directors: Edward J. Benz, Jr., Paul B. Manning, Maha Radhakrishnan, and Paul Peter Tak, with board recommending a vote in favor.

  • Ratification of KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, recommended by the board.

  • Additional business may be addressed if properly brought before the meeting or any adjournment.

Board of directors and corporate governance

  • Board recommends all four nominees for Class II director positions.

Audit committee and external auditor matters

  • Proposal to ratify KPMG LLP as the external auditor for the 2026 fiscal year.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more